Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Roche reports positive growth in first half of 2013

Roche reports positive growth in first half of 2013

25th July 2013

Roche has announced a group sales total of 23.3 billion Swiss francs (20.08 million pounds) for the first six months of 2013, up by five percent year over year.

The company's half-year financial report demonstrated a 12 percent increase in its earnings per share (EPS) total, with its pharmaceuticals and diagnostics divisions both experiencing improved performances.

Its HER2 cancer treatment portfolio grew by 11 percent following the successful launch of the new products Perjeta and Kadcyla, while Avastin sales surged by 12 percent based on strong demand in ovarian and colorectal cancer.

The firm restated its full-year financial outlook and expects that its annual sales will increase in line with last year's growth at a constant exchange rate.

Roche chief executive officer Severin Schwan said: "We will continue to focus on innovation with 68 new molecular entities in our pharma pipeline and 55 key diagnostics platforms and tests in development."

Last year, Roche generated 45.5 billion francs in yearly sales, while its core EPS figure came to 13.62 francs.ADNFCR-8000103-ID-801616581-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.